...
首页> 外文期刊>Journal of Thoracic Disease >Refractory hypertension with massive proteinuria may be reversed in renal artery stenosis patients with low proteinuria selectivity index after stenting
【24h】

Refractory hypertension with massive proteinuria may be reversed in renal artery stenosis patients with low proteinuria selectivity index after stenting

机译:支架置入术后低蛋白尿选择指数的肾动脉狭窄患者可逆转难治性高血压伴大蛋白尿

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: No available prognostic factor was identified for atherosclerotic renovascular stenosis (ARAS) patient who undergo the percutaneous revascularization therapy. Report: This is a case of 68-year-old ARAS patient associated with hypertension and massive proteinuria, who exhibited progressive aggravation of renal dysfunction. His proteinuria selectivity index (SI) was only 0.08. Then the stenosis was treated by percutaneous transluminal angioplasty of the renal artery (PTRA) and stenting. After 2-year follow up, all symptoms including renal dysfunction and uncontrolled hypertension was well-controlled. Disscussion: As no reliable predictors of clinical response have been identified yet, SI might be a simple prognositic index for ARAS patients undergone the revascularzation therapy.
机译:背景:目前尚无可利用的经皮血管再形成治疗的动脉粥样硬化性肾血管狭窄(ARAS)患者的预后因素。报告:这是一例68岁的ARAS患者,伴有高血压和大量蛋白尿,表现为肾功能不全加重。他的蛋白尿选择性指数(SI)仅为0.08。然后通过经皮肾动脉腔内血管成形术(PTRA)和支架置入术治疗狭窄。经过2年的随访,所有症状,包括肾功能不全和高血压得到控制。讨论:由于尚未确定临床反应的可靠预测指标,因此SI可能是接受血管重建治疗的ARAS患者的简单预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号